Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation.
Tatar O, Shinoda K, Kaiserling E, Claes C, Eckardt C, Eckert T, Pertile G, Boeyden V, Scharioth GB, Yoeruek E, Szurman P, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group; Grisanti S.
Tatar O, et al. Among authors: pertile g.
Br J Ophthalmol. 2009 Feb;93(2):159-65. doi: 10.1136/bjo.2008.138594. Epub 2008 Oct 6.
Br J Ophthalmol. 2009.
PMID: 18838410